New Dual Small Molecules for Alzheimer’s Disease Therapy Combining Histamine H 3 Receptor (H3R) Antagonism and Calcium Channels Blockade with Additional Cholinesterase Inhibition - Université de Franche-Comté Access content directly
Journal Articles Journal of Medicinal Chemistry Year : 2019

New Dual Small Molecules for Alzheimer’s Disease Therapy Combining Histamine H 3 Receptor (H3R) Antagonism and Calcium Channels Blockade with Additional Cholinesterase Inhibition

Rim Malek
  • Function : Author
Raquel Arribas
  • Function : Author
Alejandra Palomino-Antolin
  • Function : Author
Perle Totoson
  • Function : Author
Celine Demougeot
  • Function : Author
Tereza Kobrlova
  • Function : Author
Ondrej Soukup
Isabel Iriepa
Ignacio Moraleda
Daniel Diez-Iriepa
  • Function : Author
Justyna Godyń
  • Function : Author
Dawid Panek
  • Function : Author
Barbara Malawska
Monika Głuch-Lutwin
  • Function : Author
Barbara Mordyl
  • Function : Author
Agata Siwek
  • Function : Author
Fakher Chabchoub
José Marco-Contelles
Katarzyna Kiec-Kononowicz
  • Function : Author
Javier Egea
  • Function : Author
Cristóbal de Los Ríos
No file

Dates and versions

hal-03654642 , version 1 (28-04-2022)

Identifiers

Cite

Rim Malek, Raquel Arribas, Alejandra Palomino-Antolin, Perle Totoson, Celine Demougeot, et al.. New Dual Small Molecules for Alzheimer’s Disease Therapy Combining Histamine H 3 Receptor (H3R) Antagonism and Calcium Channels Blockade with Additional Cholinesterase Inhibition. Journal of Medicinal Chemistry, 2019, 62 (24), pp.11416-11422. ⟨10.1021/acs.jmedchem.9b00937⟩. ⟨hal-03654642⟩

Collections

UNIV-FCOMTE
9 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More